AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8174303 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 3069548 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric ulcer patients
Number of subjects: 75
Study 3069548 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal ulcer patients
Number of subjects: 75
Study 3069548 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 75
Study 2119183 — intervention group
Group type: EXPERIMENTAL
Intervention: Consistent wound care
Number of subjects: 80
Study 2119183 — intervention group
Group type: EXPERIMENTAL
Intervention: Carefully controlled nutritional support
Number of subjects: 80
Study 2119183 — intervention group
Group type: EXPERIMENTAL
Intervention: Both consistent wound care and carefully controlled nutritional support
Number of subjects: 80
Study 2119183 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital treatment
Number of subjects: 80
Study 4758446 — intervention group
Group type: EXPERIMENTAL
Intervention: Frusemide 2000 mg daily
Number of subjects: 105
Study 31043522 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal arginine vasopressin (AVP) treatment (24 IU for ages 6-9.5 years; 32 IU for ages 9.6-12.9 years)
Number of subjects: 30
Study 31043522 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal arginine vasopressin (AVP) treatment
Number of subjects: 30
Study 31043522 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 30
Study 27683405 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary sodium nitrite
Number of subjects: 80
Study 27683405 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 25372313 — intervention group
Group type: EXPERIMENTAL
Intervention: 810-nm pulsed diode laser treatment
Number of subjects: 18
Study 25372313 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 18
Study 25372313 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall score combining erythema and roughness/bumpiness for treatment
Number of subjects: 18
Study 25372313 — intervention group
Group type: COMPARATOR
Intervention: Overall score combining erythema and roughness/bumpiness for control
Number of subjects: 18
Study 23834688 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (up to 0.8 mg/kg/day)
Number of subjects: 78
Study 23834688 — intervention group
Group type: COMPARATOR
Intervention: Control (no carvedilol)
Number of subjects: 78
Study 23834688 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 78
Study 23834688 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 78
Study 21360353 — intervention group
Group type: EXPERIMENTAL
Intervention: Group CBT (Cognitive Behavioral Therapy)
Number of subjects: 12
Study 21360353 — intervention group
Group type: COMPARATOR
Intervention: Routine care alone
Number of subjects: 12
Study 19515179 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin (50 mg b.i.d.)
Number of subjects: 576
Study 19515179 — intervention group
Group type: COMPARATOR
Intervention: Pioglitazone (30 mg daily)
Number of subjects: 576
Study 19515179 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 576
Study 17274272 — intervention group
Group type: EXPERIMENTAL
Intervention: Water (group GW, n=12)
Number of subjects: 26
Study 17274272 — intervention group
Group type: COMPARATOR
Intervention: Electrolytic carbohydrate solution (group GP, n=14)
Number of subjects: 26
Study 15025744 — intervention group
Group type: EXPERIMENTAL
Intervention: Perhexiline
Number of subjects: 32
Study 15025744 — intervention group
Group type: COMPARATOR
Intervention: Control (no perhexiline)
Number of subjects: 32
Study 11424515 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary manipulation focusing on non-starch polysaccharides (NSPs), mono and disaccharide sensitivity, and food intolerance
Number of subjects: 0
Study 11424515 — intervention group
Group type: EXPERIMENTAL
Intervention: Guidelines for dietetic practice in IBS
Number of subjects: 0
Study 9549742 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 1 microgram.kg‐1 with 0.25% bupivacaine
Number of subjects: 24
Study 9549742 — intervention group
Group type: COMPARATOR
Intervention: 1 ml normal saline (placebo)
Number of subjects: 24
Study 7523785 — intervention group
Group type: EXPERIMENTAL
Intervention: Abanoquil (UK 52,046)
Number of subjects: 27
Study 3060626 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil (CPDX‐PR) 400 mg daily for 7 days
Number of subjects: 243
Study 3060626 — intervention group
Group type: COMPARATOR
Intervention: Cefaclor (CCL) 750 mg daily for 7 days
Number of subjects: 243
Study 3060626 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil (CPDX‐PR)
Number of subjects: 243
Study 3060626 — intervention group
Group type: COMPARATOR
Intervention: Cefaclor (CCL)
Number of subjects: 243
Study 28910139 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based cognitive-behavioral therapy (CBT), 10 sessions
Number of subjects: 142
Study 25940277 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus a decision aid presenting risks and benefits of different treatments (surgery and radiotherapy)
Number of subjects: 240
Study 25940277 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 240
Study 25940277 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus a decision aid
Number of subjects: 240
Study 24467988 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical score (FeverPAIN)
Number of subjects: 1760
Study 24467988 — intervention group
Group type: EXPERIMENTAL
Intervention: RAPD (Rapid Antigen Detection Test)
Number of subjects: 1760
Study 24467988 — intervention group
Group type: COMPARATOR
Intervention: Delayed antibiotics (control group)
Number of subjects: 1760
Study 22075119 — intervention group
Group type: EXPERIMENTAL
Intervention: Student-focused feedback instructional session
Number of subjects: 0
Study 22075119 — intervention group
Group type: COMPARATOR
Intervention: Compliments (Control)
Number of subjects: 0
Study 22075119 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback (Instructional)
Number of subjects: 0
Study 19801528 — intervention group
Group type: EXPERIMENTAL
Intervention: Persuasive communication goal
Number of subjects: 0
Study 19801528 — intervention group
Group type: COMPARATOR
Intervention: Accurate communication goal
Number of subjects: 0
Study 19801528 — intervention group
Group type: COMPARATOR
Intervention: Asking for an opinion
Number of subjects: 0
Study 19801528 — intervention group
Group type: COMPARATOR
Intervention: No communication goal
Number of subjects: 0
Study 17563145 — intervention group
Group type: EXPERIMENTAL
Intervention: Same context as extinction
Number of subjects: 143
Study 17563145 — intervention group
Group type: EXPERIMENTAL
Intervention: Different context
Number of subjects: 143
Study 17563145 — intervention group
Group type: EXPERIMENTAL
Intervention: Different context containing an extinction cue
Number of subjects: 143
Study 17563145 — intervention group
Group type: EXPERIMENTAL
Intervention: Different context with cue plus manipulation to increase salience
Number of subjects: 143
Study 15663405 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (400 mug oral + 400 mug intravaginal, repeated every 6 hours for a maximum of five doses)
Number of subjects: 324
Study 15663405 — intervention group
Group type: COMPARATOR
Intervention: Control group (no previous caesarean section)
Number of subjects: 324
Study 11961329 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 ml tap water with 1.0 mg F
Number of subjects: 18
Study 11961329 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 ml standard milk with 1.0 mg F
Number of subjects: 18
Study 11961329 — intervention group
Group type: COMPARATOR
Intervention: 200 ml standard milk
Number of subjects: 18
Study 11961329 — intervention group
Group type: COMPARATOR
Intervention: 200 ml F‐free tap water
Number of subjects: 18
Study 10874381 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (PCA)
Number of subjects: 0
Study 10874381 — intervention group
Group type: COMPARATOR
Intervention: Regular intramuscular (i.m.) injections of opioid analgesia
Number of subjects: 0
Study 8768863 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithyroid drugs for 18 months
Number of subjects: 179
Study 8768863 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtotal thyroidectomy
Number of subjects: 179
Study 8768863 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioiodine (iodine-131) treatment
Number of subjects: 179
Study 8768863 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 179
Study 1913523 — intervention group
Group type: EXPERIMENTAL
Intervention: Specimen sonication and multiparameter ploidy analysis (MPPA)
Number of subjects: 167
Study 1913523 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiparameter ploidy analysis (MPPA)
Number of subjects: 167
Study 1913523 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetraploid tumors
Number of subjects: 167
Study 1913523 — intervention group
Group type: EXPERIMENTAL
Intervention: Ploidy and %S
Number of subjects: 167
Study 6416664 — intervention group
Group type: EXPERIMENTAL
Intervention: Total lymphoid fields (TLI)
Number of subjects: 124
Study 6416664 — intervention group
Group type: COMPARATOR
Intervention: Involved field (IF)
Number of subjects: 124
Study 6416664 — intervention group
Group type: COMPARATOR
Intervention: Extended field (EF)
Number of subjects: 124
Study 6416664 — intervention group
Group type: EXPERIMENTAL
Intervention: Megavoltage irradiation (general treatment)
Number of subjects: 124
Study 6416664 — intervention group
Group type: EXPERIMENTAL
Intervention: Nodular Histiocytic (NH)
Number of subjects: 124
Study 30728951 — intervention group
Group type: EXPERIMENTAL
Intervention: Double antibiotic paste (DAP)
Number of subjects: 36
Study 30728951 — intervention group
Group type: COMPARATOR
Intervention: Calcium hydroxide (CH)
Number of subjects: 36
Study 26464453 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.06 mg/kg Sildenafil (Sild-L group)
Number of subjects: 39
Study 26464453 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 mg/kg Sildenafil (Sild-H group)
Number of subjects: 39
Study 26464453 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control group)
Number of subjects: 39
Study 25012407 — intervention group
Group type: EXPERIMENTAL
Intervention: Clutter condition
Number of subjects: 34
Study 25012407 — intervention group
Group type: COMPARATOR
Intervention: Non-clutter condition
Number of subjects: 34
Study 22847059 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (8 mg once daily for 6 weeks)
Number of subjects: 35
Study 22847059 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 22847059 — intervention group
Group type: COMPARATOR
Intervention: Rosiglitazone vs Placebo
Number of subjects: 35
Study 19625385 — intervention group
Group type: EXPERIMENTAL
Intervention: D2‐like agonist (Bromocriptine, 1.25 mg)
Number of subjects: 0
Study 19625385 — intervention group
Group type: EXPERIMENTAL
Intervention: D2‐like antagonist (Sulpiride, 400 mg)
Number of subjects: 0
Study 19625385 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17360794 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-generated tailored written information
Number of subjects: 138
Study 17360794 — intervention group
Group type: COMPARATOR
Intervention: Generic written information
Number of subjects: 138
Study 16373945 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation
Number of subjects: 70
Study 16373945 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocaloric diet with 30% protein, 30% fat, and 40% carbohydrate; increased physical activity
Number of subjects: 70
Study 16373945 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocaloric diet and increased physical activity
Number of subjects: 70
Study 12200242 — intervention group
Group type: EXPERIMENTAL
Intervention: British subjects over 50 years old
Number of subjects: 0
Study 12200242 — intervention group
Group type: EXPERIMENTAL
Intervention: British women
Number of subjects: 0
Study 12200242 — intervention group
Group type: EXPERIMENTAL
Intervention: British men
Number of subjects: 0
Study 12200242 — intervention group
Group type: COMPARATOR
Intervention: US NHANES III data
Number of subjects: 0
Study 10456967 — intervention group
Group type: EXPERIMENTAL
Intervention: Multipuncture method (Heaf gun)
Number of subjects: 169
Study 10456967 — intervention group
Group type: COMPARATOR
Intervention: Intradermal method
Number of subjects: 169
Study 7794875 — intervention group
Group type: COMPARATOR
Intervention: Western-type control diet for six weeks
Number of subjects: 38
Study 7794875 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified diet with 70% of the fat replaced by palm oil
Number of subjects: 38
Study 2190547 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% MK-927
Number of subjects: 27
Study 2190547 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 2190547 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% MK-927
Number of subjects: 27
Study 2190547 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% MK-927
Number of subjects: 27
Study 2190547 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% MK-927 (part C)
Number of subjects: 27
Study 574397 — intervention group
Group type: EXPERIMENTAL
Intervention: Argon laser photocoagulation
Number of subjects: 0
Study 574397 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 0
Study 31375422 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 4398
Study 31375422 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4398
Study 27778256 — intervention group
Group type: EXPERIMENTAL
Intervention: Trans-perineal repair with limited internal sphincterotomy (group II)
Number of subjects: 62
Study 27778256 — intervention group
Group type: COMPARATOR
Intervention: Trans-perineal repair alone (group I)
Number of subjects: 62
Study 26223543 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab (24 mg/m², maximum dose 40 mg every other week)
Number of subjects: 46
Study 26223543 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 26223543 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 46
Study 23500260 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine 0.5 mg twice daily
Number of subjects: 196
Study 23500260 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study 21713700 — intervention group
Group type: EXPERIMENTAL
Intervention: Antecolic gastroenteric anastomosis (group A, 20 cases)
Number of subjects: 40
Study 21713700 — intervention group
Group type: COMPARATOR
Intervention: Retrocolic gastroenteric anastomosis (group B, 20 cases)
Number of subjects: 40
Study 21713700 — intervention group
Group type: EXPERIMENTAL
Intervention: Antecolic and retrocolic anastomosis (both groups)
Number of subjects: 40
Study 19281922 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin therapy
Number of subjects: 6500000
Study 19281922 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 6500000
Study 17407516 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg/day for 2 weeks before and after TURP, or 4 weeks before and 2 weeks after TURP
Number of subjects: 214
Study 17407516 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study 17407516 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 214
Study 15184247 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib (100 or 400 mg twice daily)
Number of subjects: 32
Study 15184247 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 11167590 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthopaedic management/patient‐focused care unit (OMPFCU)
Number of subjects: 0
Study 11167590 — intervention group
Group type: COMPARATOR
Intervention: Standard care in the orthopaedic surgery wards
Number of subjects: 0
Study 9605372 — intervention group
Group type: EXPERIMENTAL
Intervention: Autotransfusion of shed mediastinal blood every hour for 18 hours (Group I)
Number of subjects: 23
Study 9605372 — intervention group
Group type: COMPARATOR
Intervention: Accumulation of shed mediastinal blood for 4 hours followed by autotransfusion every hour for the next 14 hours (Group II)
Number of subjects: 23
Study 9605372 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro study with stimulation (PHA and E. coli LPS)
Number of subjects: 23
Study 8809927 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded activation intervention
Number of subjects: 103
Study 8809927 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 103
Study 2109729 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin plus sublingual nitroglycerin (group I)
Number of subjects: 34
Study 2109729 — intervention group
Group type: COMPARATOR
Intervention: Balloon tamponade (group II)
Number of subjects: 34
Study 7013560 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine combined with diazepam
Number of subjects: 64
Study 29020472 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS combined with SOP CRT
Number of subjects: 33
Study 29020472 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS combined with SOP CRT
Number of subjects: 33
Study 28683809 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU plus the offer of an intervention
Number of subjects: 0
Study 28683809 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study 24916808 — intervention group
Group type: EXPERIMENTAL
Intervention: Bushen Huoxue Granule (BHG) with baseline levodopa and benserazide (Madopar)
Number of subjects: 120
Study 24916808 — intervention group
Group type: COMPARATOR
Intervention: Placebo with baseline levodopa and benserazide (Madopar)
Number of subjects: 120
Study 26265273 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod 0.5mg
Number of subjects: 1053
Study 26265273 — intervention group
Group type: COMPARATOR
Intervention: iDMT
Number of subjects: 1053
Study 22525474 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabergoline
Number of subjects: 91
Study 22525474 — intervention group
Group type: COMPARATOR
Intervention: Levodopa
Number of subjects: 91
Study 19415122 — intervention group
Group type: EXPERIMENTAL
Intervention: WR279,396 applied twice a day for 20 days
Number of subjects: 92
Study 19415122 — intervention group
Group type: COMPARATOR
Intervention: Vehicle-placebo
Number of subjects: 92
Study 19415122 — intervention group
Group type: EXPERIMENTAL
Intervention: WR279,396
Number of subjects: 92
Study 17319806 — intervention group
Group type: EXPERIMENTAL
Intervention: Coordinated care model
Number of subjects: 4603
Study 17319806 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 4603
Study 15543027 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen therapy
Number of subjects: 0
Study 15543027 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone therapy (combined with estrogen)
Number of subjects: 0
Study 11201419 — intervention group
Group type: EXPERIMENTAL
Intervention: Holding and sucrose taste (holding and sucrose group)
Number of subjects: 85
Study 11201419 — intervention group
Group type: EXPERIMENTAL
Intervention: Holding and water taste (holding group)
Number of subjects: 85
Study 11201419 — intervention group
Group type: EXPERIMENTAL
Intervention: No holding and sucrose taste (sucrose group)
Number of subjects: 85
Study 11201419 — intervention group
Group type: COMPARATOR
Intervention: No holding and water taste (control participants)
Number of subjects: 85
Study 11201419 — intervention group
Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 85
Study 8776361 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical potent glucocorticoid treatment (betamethasone-17-valerate) applied twice a day for 3 days
Number of subjects: 28
Study 8776361 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid treatment
Number of subjects: 28
Study 1415406 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibroacoustic stimulation over the fetal vertex (n = 115)
Number of subjects: 205
Study 1415406 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibroacoustic stimulation over the fetal breech (n = 90)
Number of subjects: 205
Study 3935463 — intervention group
Group type: EXPERIMENTAL
Intervention: Glibenclamide instilled into the stomach
Number of subjects: 14
Study 3935463 — intervention group
Group type: EXPERIMENTAL
Intervention: Glibenclamide instilled into the duodenum
Number of subjects: 14
Study 3935463 — intervention group
Group type: EXPERIMENTAL
Intervention: Glibenclamide instilled into the colon
Number of subjects: 14
Study 30950928 — intervention group
Group type: EXPERIMENTAL
Intervention: Original abutments (Group I)
Number of subjects: 20
Study 30950928 — intervention group
Group type: COMPARATOR
Intervention: Nonoriginal abutments (Group II)
Number of subjects: 20
Study 29845187 — intervention group
Group type: EXPERIMENTAL
Intervention: Words Sequence Test (WST) with a 4-word sequence
Number of subjects: 52
Study 29845187 — intervention group
Group type: COMPARATOR
Intervention: Current speech-in-noise tests (control group)
Number of subjects: 52
Study 27261995 — intervention group
Group type: EXPERIMENTAL
Intervention: Active group music therapy
Number of subjects: 14
Study 27261995 — intervention group
Group type: EXPERIMENTAL
Intervention: Receptive group music therapy
Number of subjects: 14
Study 27261995 — intervention group
Group type: COMPARATOR
Intervention: Group counseling
Number of subjects: 14
Study 24226487 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol TCI
Number of subjects: 80
Study 24226487 — intervention group
Group type: COMPARATOR
Intervention: Thiopental TCI
Number of subjects: 80
Study 22827903 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevention intervention for women offenders
Number of subjects: 344
Study 22827903 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 344
Study 21166627 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume assured non‐invasive ventilation
Number of subjects: 25
Study 21166627 — intervention group
Group type: COMPARATOR
Intervention: Pressure preset non‐invasive ventilation
Number of subjects: 25
Study 19674695 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom-made flexible orthotics with the same exercise program
Number of subjects: 13
Study 19674695 — intervention group
Group type: COMPARATOR
Intervention: Control group (no orthotics) with the same exercise program
Number of subjects: 13